Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03080685
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
FD4 | N-ALPHA-(2-NAPHTHYLSULFONYL)-N(3- AMIDINO-L-PHENYLALANINYL)-4-ACETYL- PIPERAZINE | A | 1K1M | 0.74 | |
SK1 | N-(BENZYLSULFONYL)-D-SERYL-N-{4- [AMINO(IMINO)METHYL]BENZYL}-L-ALANINAMIDE | U | 1W11 | 0.75 | |
GVR | (2R)-N-hydroxy-3-naphthalen-2-yl- 2-[(naphthalen-2-ylsulfonyl)amino]propanamide | A,B,C | 2VES | 0.7 | |
IZD | ISOTHIAZOLIDINONE ANALOG | A | 2CM7 | 0.72 | |
C3M | N-[(2R,3S)-3-AMINO-2-HYDROXY-4- PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE | B,I | 2C8Y | 0.71 | |
MUW | N-{(5S)-5-[{[4-(AMINOMETHYL)PHENYL]SULFONYL}(ISOBUTYL)AMINO]- 6-HYDROXYHEXYL}-NALPHA-(METHOXYCARBONYL)- BETA-PHENYL-L-PHENYLALANINAMIDE | A,B | 2Q3K | 0.75 | |
SI1 | N-(BUTYLSULFONYL)-D-SERYL-N-{4- [AMINO(IMINO)METHYL]BENZYL}-L-ALANINAMIDE | U | 1W0Z | 0.73 | |
EG3 | PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE | A | 1CNY | 0.71 | |
PSM | N-[DIHYDROXY(PROPYL)-LAMBDA~4~- SULFANYL]THREONYL-N~1~-{4-[AMINO(IMINO)METHYL]BENZYL}METHIONINAMIDE | H,L | 1WQV | 0.71 | |
LP1 | 4-[2-(2-ACETYLAMINO-3-NAPHTALEN- 1-YL-PROPIONYLAMINO)-4-METHYL-PENTANOYLAMINO]- 3-HYDROXY-6-METHYL-HEPTANOIC ACID [1- (1-CARBAMOYL-2-NAPHTHALEN-1-YL- ETHYLCARBAMOYL)-PROPYL]-AMIDE | A | 4FIV | 0.72 | |
LP1 | 4-[2-(2-ACETYLAMINO-3-NAPHTALEN- 1-YL-PROPIONYLAMINO)-4-METHYL-PENTANOYLAMINO]- 3-HYDROXY-6-METHYL-HEPTANOIC ACID [1- (1-CARBAMOYL-2-NAPHTHALEN-1-YL- ETHYLCARBAMOYL)-PROPYL]-AMIDE | A | 1ODY | 0.72 | |
LP1 | 4-[2-(2-ACETYLAMINO-3-NAPHTALEN- 1-YL-PROPIONYLAMINO)-4-METHYL-PENTANOYLAMINO]- 3-HYDROXY-6-METHYL-HEPTANOIC ACID [1- (1-CARBAMOYL-2-NAPHTHALEN-1-YL- ETHYLCARBAMOYL)-PROPYL]-AMIDE | A | 2FMB | 0.72 | |
FD3 | N-ALPHA-(2-NAPHTHYLSULFONYL)-3- AMIDINO-L-PHENYLALANINE PIPERAZIDE | A | 1K1L | 0.74 | |
NFT | N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'- (AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2- TRIFLUOROETHYL}-L-LEUCINAMIDE | A | 1VSN | 0.71 | |
SH1 | N-[(2-PHENYLETHYL)SULFONYL]-D-SERYL- N-[(1S)-4-[(DIAMINOMETHYLENE)AMINO]- 1-(HYDROXYMETHYL)BUTYL]-L-ALANINAMIDE | U | 1W14 | 0.8 | |
HYB | [2-(2-METHYL-PROPANE-2-SULFONYLMETHYL)- 3-NAPHTHALEN-1-YL-PROPIONYL-VALINYL]- PHENYLALANINOL | A | 1FMB | 0.72 | |
IZ4 | N-{(1S)-2-{4-[(5S)-1,1-dioxido- 3-oxoisothiazolidin-5-yl]phenyl}- 1-[(4R)-4-(2-phenylethyl)-4,5-dihydro- 1H-imidazol-2-yl]ethyl}-3-fluorobenzenesulfonamide | A | 2VEX | 0.7 | |
JT5 | N~2~-(biphenyl-4-ylsulfonyl)-N- hydroxy-N~2~-(2-hydroxyethyl)glycinamide | A | 2JT5 | 0.72 | |
RA8 | N-(BENZYLSULFONYL)-L-LEUCYL-N-(4- {[AMINO(IMINO)METHYL]AMINO}BUTYL)- L-PROLINAMIDE | H,I | 1YPL | 0.71 | |
730 | (S)-3-(3-(4-(2-GUANIDINOETHYL)PIPERIDIN- 1-YL)-2-(NAPHTHALENE-2-SULFONAMIDO)- 3-OXOPROPYL)BENZIMIDAMIDE | A | 2GV6 | 0.73 | |
MIU | N-{(1S)-1-{[4-(3-AMINOPROPYL)PIPERAZIN- 1-YL]CARBONYL}-4-[(DIAMINOMETHYLENE)AMINO]BUTYL}- 3-(TRIFLUOROMETHYL)BENZENESULFONAMIDE | H | 1W7G | 0.75 | |
TP2 | N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL | A,B | 1F4D | 0.71 | |
TP2 | N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL | A,B | 1F4C | 0.71 | |
BM2 | S-(R*,R*)]-4-[AMINOIMINOMETHYL)AMINO]- N-[[1-[3-HYDROXY -2-[(2-NAPHTHALENYLSULFONYL)AMINO]- 1-OXOPROPYL]-2-PYRROLIDINYL] METHYL]BUTANAMIDE | H | 1BMM | 0.95 | |
YDP | (3S,4S),-3,4-Bis-[(4-carbamoyl- benzensulfonyl)-(3-methyl-but-2- enyl)-amino]-pyrrolidine | A | 2ZGA | 0.7 | |
YDP | (3S,4S),-3,4-Bis-[(4-carbamoyl- benzensulfonyl)-(3-methyl-but-2- enyl)-amino]-pyrrolidine | A,B | 3CKT | 0.7 | |
SBL | L-NAPHTHYL-1-ACETAMIDO BORONIC ACID ALANINE | A | 1AV7 | 0.73 | |
3CC | N-[(2R)-5-(aminosulfonyl)-2,3-dihydro- 1H-inden-2-yl]-2-propylpentanamide | A | 2QO8 | 0.72 | |
GSJ | 1-PYRROLIDINEACETAMIDE, 3-[[(6- CHLORO-2-NAPHTHALENYL)SULFONYL]AMINO]- ALPHA-METHYL-N-(1-METHYLETHYL)- N-[2-[(METHYLSULFONYL)AMINO]ETHYL]- 2-OXO-, (ALPHAS,3S)- | A | 2J4I | 0.77 | |
2IN | N-(BENZYLSULFONYL)SERYL-N~1~-{4- [AMINO(IMINO)METHYL]BENZYL}GLYCINAMIDE | U | 1SC8 | 0.75 | |
7IN | N-(BENZYLSULFONYL)SERYL-N~1~-{4- [(Z)-AMINO(IMINO)METHYL]BENZYL}SERINAMIDE | U | 1VJA | 0.75 | |
FD2 | N-ALPHA-(2-NAPHTHYLSULFONYL)-N(3- AMIDINO-L-PHENYLALANINYL)ISOPIPECOLINIC ACID METHYL ESTER | A | 1K1J | 0.73 | |
FD1 | N-ALPHA-(2-NAPHTHYLSULFONYL)-N- (3-AMIDINO-L-PHENYLALANINYL)-D- PIPECOLINIC ACID | A | 1K1I | 0.74 | |
GSK | 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL- 2-(4-MORPHOLINYL)-2-OXO ETHYL]- 2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE | A | 2CJI | 0.76 | |
MID | N==ALPHA==(2-NAPHTHYL-SULFONYL- GLYCYL)-PARA-AMIDINOPHENYL-ALANYL- PIPERIDINE | H | 1DWD | 0.75 | |
BM9 | [S-(R*,R*)]-1-(AMINOIMINOMETHYL)- N-[[1-[N-[(2-NAPHTHALENYLSULFONYL)- L-SERYL]-3-PYRROLIDINYL]METHYL]- 3-PIPERIDENECARBOXAMIDE | H | 1BMN | 0.89 | |
SBD | D-NAPHTHYL-1-ACETAMIDO BORONIC ACID ALANINE | A | 3VSB | 0.73 |